Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines (Hepatology International, (2021), 15, 6, (1421-1430), 10.1007/s12072-021-10263-x)

Wei Teng, Ting Tsung Chang, Hwai I. Yang, Cheng Yuan Peng, Chien Wei Su, Tung Hung Su, Tsung Hui Hu, Ming Lung Yu, Hung Chih Yang, Jaw Ching Wu

研究成果: Comment/debate同行評審

指紋

深入研究「Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines (Hepatology International, (2021), 15, 6, (1421-1430), 10.1007/s12072-021-10263-x)」主題。共同形成了獨特的指紋。

Medicine & Life Sciences